Join the Brixadi group to help and get support from people like you.
Brixadi News (Page 2)
FDA Approves Brixadi (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder
Plymouth Meeting, Pa. – May 23, 2023—Braeburn announces that the U.S. Food and Drug Administration (FDA) has approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (CIII), a...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Opiate Dependence - Maintenance, Opiate Dependence